Objective Inhaled corticosteroids (ICS) are generally used to treat patients with chronic
obstructive pulmonary disease (COPD) who suffer from repeated exacerbations. Recently, it …

Background: Whether all types of inhaled corticosteroids (ICSs) would increase the
pneumonia risk in patients with chronic obstructive pulmonary disease (COPD) remains …

ICS are anti-inflammatory agents which have been suggested to benefit people with
worsening symptoms of COPD, by improving lung function, reducing exacerbation of …

Background: Inhaled corticosteroids are commonly prescribed for patients with severe
COPD. They have been associated with increased risk of pneumonia but not with increased …

Background The use of inhaled corticosteroids in patients with chronic obstructive
pulmonary disease (COPD) has been associated with an increased risk of pneumonia in …

Inhaled corticosteroids (ICSs) treatment combined with long-acting β2-adrenoceptor
agonists (LABAs) reduces the risk of exacerbations in COPD, but the use of ICSs is …

Recent studies have suggested that inhaled corticosteroids (ICS) may be associated with
higher risks of tuberculosis and pneumonia in patients with COPD. However, it is not known …

Background Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in
patients with chronic obstructive pulmonary disease (COPD). It is unclear whether the risk of …

Introduction Inhaled corticosteroids (ICSs) are recommended for patients with frequent
exacerbation of chronic obstructive pulmonary disease (COPD). However, accumulating …

Background Recent studies have suggested a possible association between pneumonia
and the use of inhaled corticosteroids. We aimed to ascertain the risk of pneumonia with …